These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6230987)

  • 1. Huntington's disease: survival of large striatal neurons in the rigid variant.
    Bugiani O; Tabaton M; Cammarata S
    Ann Neurol; 1984 Feb; 15(2):154-6. PubMed ID: 6230987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia.
    Albin RL; Reiner A; Anderson KD; Penney JB; Young AB
    Ann Neurol; 1990 Apr; 27(4):357-65. PubMed ID: 1972318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
    Watson DL; Carpenter CL; Marks SS; Greenberg DA
    Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A morphometric reevaluation of Huntington's chorea with special reference to the large neurons in the neostriatum.
    Oyanagi K; Ikuta F
    Clin Neuropathol; 1987; 6(2):71-9. PubMed ID: 2954733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
    Cicchetti F; Parent A
    Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative investigation of the substantia nigra in Huntington's disease.
    Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
    Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuropathological features of neuroacanthocytosis.
    Rinne JO; Daniel SE; Scaravilli F; Pires M; Harding AE; Marsden CD
    Mov Disord; 1994 May; 9(3):297-304. PubMed ID: 8041370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of acute cell loss in Huntington's chorea brain.
    Averback P
    J Pathol; 1980 Sep; 132(1):55-61. PubMed ID: 6448921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ; Shannak K; Hornykiewicz O
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats.
    Kántor O; Temel Y; Holzmann C; Raber K; Nguyen HP; Cao C; Türkoglu HO; Rutten BP; Visser-Vandewalle V; Steinbusch HW; Blokland A; Korr H; Riess O; von Hörsten S; Schmitz C
    Neurobiol Dis; 2006 Jun; 22(3):538-47. PubMed ID: 16480885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical phenotype of calretinin interneurons in the human striatum.
    Cicchetti F; Beach TG; Parent A
    Synapse; 1998 Nov; 30(3):284-97. PubMed ID: 9776132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compactotomy in Huntington's chorea.
    Bonelli RM; Kenner L; Gruber A; Reisecker F; Költringer P
    Med Hypotheses; 2001 Oct; 57(4):491-6. PubMed ID: 11601877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
    Ariano MA; Wagle N; Grissell AE
    J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity.
    Liang ZQ; Wang XX; Wang Y; Chuang DM; DiFiglia M; Chase TN; Qin ZH
    Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
    Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study.
    Kiferle L; Mazzucchi S; Unti E; Pesaresi I; Fabbri S; Nicoletti V; Volterrani D; Cosottini M; Bonuccelli U; Ceravolo R
    Parkinsonism Relat Disord; 2013 Sep; 19(9):800-5. PubMed ID: 23769177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of the large striatal interneurons expressing calretinin in Huntington's disease.
    Massouh M; Wallman MJ; Pourcher E; Parent A
    Neurosci Res; 2008 Dec; 62(4):216-24. PubMed ID: 18801393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.